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Summary:
Background: Non-governmental personnel such as Anganwadi workers and community volunteers have been used as
directly observed treatment (DOT) providers in the Revised National Tuberculosis Control Programme (RNTCP), but
their effectiveness has not been documented.
Aim: To assess the treatment outcome and problems encountered by patients managed by different DOT providers in the
RNTCP.
Material and Methods: Patients diagnosed with tuberculosis at 17 Primary Health Institutions (PHIs) in Tiruvallur
District during a 3-year period received DOT from one of the four types of trained DOT providers (PHI staff,
governmental outreach workers, Anganwadi workers, community volunteers), and their treatment outcomes were
compared.  Of the 1131 new smear-positive patients treated between May 1999 through June 2002, 199 (18%) received
DOT from PHI staff, 238(21%) from outreach workers, 496 (44%) from Anganwadi workers, and 170 (15%) from
community volunteers. Twenty-eight patients (2%) collected drugs for self-administration.
Results: Treatment success rates among patients treated by different DOT providers, Anganwadi workers (80%),
governmental outreach workers (81%), community volunteers (76%) and PHI staff (76%), were statistically similar.
Patients who received drugs for self-administration were significantly more likely to fail to treatment or die than
patients who were treated by a DOT provider (5/28 versus 84/1103; odds ratio=4.1; 95% confidence interval=1.2-12.6;
p=0.02).
Conclusion: In addition to governmental staff, Anganwadi workers and community volunteers can be effectively
utilized as DOT providers.
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INTRODUCTION
The necessity of directly observed
treatment (DOT) for tuberculosis control was first
demonstrated in India1.   DOT is now
recommended as the standard of care in treatment
of tuberculosis worldwide2-3.  By ensuring that
patients take the right drugs, at the right intervals
and in the right dosages, DOT reduces the chances
of relapse or failure and prevents multi-drug
resistant tuberculosis4-6.  While DOT is central to
the success of tuberculosis control programmes,
it is not easy to implement.  DOT needs to be
given at a location, which is convenient to the
patient, and, by a treatment provider who is
accountable to the health system.  Several types
of providers have successfully carried out
treatment observation in various countries. They
include health workers in China, community
volunteers in Africa, religious leaders in Philippines
and members of non-governmental organizations
in Bangladesh7-11.
The Revised National Tuberculosis
Programme (RNTCP) in India, based on the
principles of Directly Observed Treatment, Short-
course (DOTS), is one of the largest and fastest
growing TB control programmes in the world 12.
The RNTCP places most responsibility of
treatment observation on the governmental health
workers at primary health Institutions (PHIs).  To
make DOT more convenient to patients, DOT
providers from the non-governmental sector, such
as Anganwadi workers and community volunteers
have been deployed in some districts, but their
effectiveness has not been documented.  In this
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paper, we analyze the treatment outcomes, and
problems encountered by patients managed by
different DOT providers in the RNTCP.
MATERIAL  AND  METHODS
Study area and patients
We are reporting from a rural population
of 580,000 in Tiruvallur District, Tamil Nadu.  The
RNTCP has been implemented in the area since
May 1999 at 17 governmental Primary Health
Institutions (PHIs) offering clinic based care and
102 sub-centres providing outreach care.  Patients
registered for anti-TB treatment at any of the
governmental PHIs from May 1999 to June 2002
were included in the analysis.  Patients were
treated as per the RNTCP guidelines with one of
the three regimens: 2H3R3Z3E3/ 4H3R3, 2H3R3Z3E3S3
/ 1H3R3Z3E3/5H3R3E3, and 2H3R3Z3/ 4H3R3.  The
treatment under RNTCP is given thrice weekly
on alternate days. Every dose of treatment is given
under direct observation in the initial intensive
phase and at least the first of the three doses is
directly observed during the continuation phase.
DOT providers
The RNTCP training modules for PHI
medical officers emphasize the need to identify a
suitable DOT provider for each patient.  In the
present study, medical officers assigned one of
the four types of DOT providers to each patient
depending upon the availability of a trained DOT
provider and the proximity of the provider to the
patient’s home: 1) health workers from the
governmental PHIs (pharmacists, and laboratory
technicians); 2) outreach health workers in charge
of the government run sub-centres (auxiliary
nurse midwives, village health nurses and health
inspectors); 3) Anganwadi workers providing non-
formal education to pre-school children in the
village under the Integrated Child Development
Services Scheme; 4) community volunteers such
as religious leaders, school teachers, shopkeepers
residing in patient’s village or a nearby village.
Although the necessity of DOT is strongly
emphasized in the RNTCP, a small proportion of
patients collected their medications for self-
administration.
Data collection
The treatment card of each patient was
reviewed to obtain details about disease
classification and treatment outcome. Trained
paramedical worker contacted each patient
approximately two months after start of treatment
and obtained information on the type of provider,
from whom the patient received directly observed
treatment.  Further information regarding the
various kinds of problems encountered during
treatment was collected from a subset of
consecutive patients registered between
November 2000 and June 2002. For the purpose
of analysis, the types of problems encountered
during treatment were categorized into four
groups, namely those related to (i) the treatment
drugs, (ii) the health centre (iii) the DOT provider,
and (iv) those of a personal nature.
Statistical analysis
The data were computerized, cross-
checked and edited for any mistakes and missing
information.  Univariate analysis was performed
using EpiInfo version 6.04 (CDC, Atlanta, GA,
July 1996). Differences in proportions were tested
by the Chi square test. Fisher’s exact test was
used when an expected cell value was less than
5. Yate’s corrected two-tailed p-value of <0.05
was considered significant.
RESULTS
Of the 3019 patients registered for anti-
tuberculosis treatment during the period of the
study, 88% (2661) could be contacted for an
interview. Of these, 543 (20%) received DOT
from staff working at the PHIs, 561 (21%) from
governmental outreach workers, 1118 (42%) from
Anganwadi  workers, and 377 (14%) from
community volunteers.  Sixty two  (2%) of the
patients collected drugs for self- administration.
The median age of patients was 43 years and 2237
(74%) were males; 1820 (68%) were employed.
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In univariate analysis, patients assigned to the
different types of DOT providers had similar
socio-demographic characteristics. In all, 87%
(2042/2343) patients found DOT convenient; this
proportion did not differ significantly by the type
of DOT provider. We are presenting treatment
outcome for 1131 new smear positive patients
treated in category I during the period according
to the type of provider.
Among the 1131 new smear-positive
patients, 199 (18%) received DOT from staff
working at the PHIs, 238 (21%) from outreach
workers, 496 (44%) from Anganwadi workers,
and 170 (15%) from community volunteers.
Twenty-eight patients (2%) collected drugs for
self-administration (Table1). Of these, 864 (76%)
were male and 782 (69%) were employed.
We analysed the treatment outcome
among new smear-positive patients by type of
DOT providers and found that the treatment
success rate was the highest among patients
receiving DOT from the governmental outreach
workers (81%); for Anganwadi workers, the
figure was 80%, followed by community
volunteers (76%).  Patients treated by PHI staff
had the lowest observed treatment success rate
74% (Table 1).  However, the differences in
treatment success rates among patients treated
by different DOT providers were not statistically
significant. Patients who received drugs for self-
administration had a treatment success of 75%.
Patients treated by community volunteers had high
default rates (18%), as did patients receiving DOT
from PHI staff (17%). Patients who received
drugs for self-administration were significantly
more likely to be failures of treatment or die, than
patients who were treated by a DOT provider
(5/28 versus 84/1103; Odds Ratio=4.1; 95%
Confidence Interval=1.2-12.6; p=0.02).
We interviewed 1662 (92%) of 1815
patients registered for treatment from November
2000 to June 2002, for problems related to taking
drugs.  Among these, 982 (59%) patients reported
having some problems due to drugs, 22% had
personal problems, 15% reported disruption in the
work routine; only 2% patients found the location
of the DOT centre inconvenient.  Giddiness was
the main complaint of patients reporting drug
related problems.  Patients receiving DOT from
Anganwadi workers or community workers were
more likely to report drug related problems than
those receiving DOT from governmental outreach
workers or PHI staff (Table 2). New smear-
positive patients reporting drug related problems
had similar treatment success rates compared with
patients who did not have such problems (75.2%
vs. 74.9%).
DISCUSSION
We found that tuberculosis patients, who
Table 1: Treatment outcome by type of DOT provider among new smear-positive patients
DIRECTLY OBSERVED TREATMENT PROVIDERS AND TB CONTROL PROGRAMME
Type of provider 
Treatment 
success
*
 
 Default 
  
 Died 
  
 Failure 
  
Total 
  
  No. % No. % No. % No. % No. % 
Governmental PHI 
health workers 147 74 34 17   7 4 11 4  199  19 
Governmental out 
reach workers 193 81 27 11   7 3 11 5  238  25 
Anganwadi workers 397 80 61 12 15 3 23 3  496  39 
Community 
volunteers 129 76 31 18   3 0   7 3  170  12 
Self-administration   21 75  2   7   3    13  2 9    28   5 
Total 887 80 155 13 35      3 54 4 1131 100 
*
 includes patients who were cured or those who completed treatment 
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received drugs for self-administration, had a
significantly higher risk of treatment failure or death
compared to patients who received treatment from
a DOT provider.  This finding is corroborated by an
earlier study from Kerala, which demonstrated that
patients who self-administered anti-TB drugs were
15 times more likely to be failures of treatment or
have a relapse than those who received treatment
under direct observation4.  High treatment success
rates can be achieved by identifying DOT providers,
who are accessible and acceptable to patients.  In
Africa, volunteers and community health workers
successfully delivered community-based DOT and
were able to maintain higher treatment completion
rates than the health worker in a clinic8. In this study,
patients receiving DOT from PHI-based providers
had the lowest treatment success rate, indicating that
proximity and convenience of DOT is essential for
improving treatment success rates. While a
decentralized approach using a network of
community-based DOT providers can take DOT
delivery closer to patients’ homes, use, training, and
supervision of community-based DOT providers may
not be optimal in the RNTCP as currently
implemented. Medical officers in charge of PHIs
monitor activities of the governmental staff through
weekly review meetings.  However, periodic
supervision of Anganwadi workers and community
volunteers is infrequent.  To increase the
accountability of community-based DOT providers,
it is necessary to develop and test mechanisms for
supervising these providers.
Although 59% of the patients in the study
reported drug related problems, 75% of these patients
completed treatment successfully. Poor treatment
outcomes were no more common among patients
who reported drug related problems than among
those who did not. Patients treated by Anganwadi
workers and community volunteers, however, were
more likely to report drug related problems than those
receiving treatment from government providers.
Governmental DOT providers are skilled in tackling
patients’ drug related complaints, whereas
Anganwadi workers and community volunteers have
minimal training in health related issues.  Therefore,
the training of Anganwadi workers and community
volunteers should include a strong component, on
how to counsel patients who have drug related
problems.  Anganwadi workers and community
volunteers may also be trained to dispense minor
drugs such as antacids, analgesics and antihistamines.
Volunteer health workers have been successfully
trained to dispense similar drugs in primary health
care programmes in India and elsewhere 13-14.
This study has at least three limitations.
First, we were unable to collect information from all
the patients about the type of provider from whom
they received DOT; patients who could not be
interviewed and thus, from whom this information
was not available, were more likely to have a poor
outcome than those who were interviewed.
Treatment success rates categorized by type of DOT
provider could differ from those reported here, if
information on the type of DOT provider was available
for all patients.  Second, it is possible that the patients
who reported that they received treatment under
direct observation may not have actually received
DOT strictly as per the RNTCP guidelines. Reliable
Table 2: Drug-related problems reported by patients
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Type of DOT provider 
Problem due to 
drugs (%) 
No problem due 
to drugs (%) P value 
Governmental PHI workers  
Governmental outreach workers 
Anganwadi workers 
Community volunteers 
Self-administration 
        137 (48) 
        153 (47) 
        431 (56) 
        153 (54) 
            3 (50) 
       146 (52) 
       174 (53) 
       333 (44) 
       129 (46) 
           3 (50) 
Controls 
0.2 
   0.003 
   0.002 
 0.08 
Total         877 (53)        785 (47)  
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information on whether patients received DOT or
not was unavailable. Finally, there may be
confounding factors other than those studied here,
which could affect treatment outcomes.
In summary, the findings of this study
indicate that in addition to governmental DOT
providers, Anganwadi workers and community
volunteers can be effectively utilized as DOT
providers in the RNTCP. This study again
confirms that the TB drugs should not be handed
over to patients for self-administration. The
importance of participating in directly observed
treatment should be effectively communicated
to patients as well as DOT providers.
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ANTI TB WEEK – 17TH TO 23RD FEBRUARY, 2005
One of the important activities of the Tuberculosis Association of India, every year, is
celebration of Anti-Tuberculosis Week throughout the country from 17th to 23rd February.
This year also, we celebrated this week from 17th to 23rd February in the premises of TB
Association of India.  St. John Ambulance Brigade played a vital role in this programme in
collaboration with Delhi TB Association.    The special feature of this campaign was to create
awareness of the TB disease amongst the public through school children. The Association also
organised an exhibition on RNTCP/DOTS, which spell out programme as well as screening of
film on Tuberculosis in the premises.  Besides this, on 20th February, 2005 a painting competition
for the school children was also organised.
Over 1500 children from 35 schools took part in the painting competition.  The objective
is to create awareness about tuberculosis through children to their families, who are considered
strong communication channels.  Dr. R.N. Baishya, Director of Health Services, Delhi
Government inaugurated the competition.  Dr. M.M. Singh, Vice Chairman, TB Association of
India highlighted the need for the awareness programme to make the anti-TB programme
successful and useful. The subject was depiction of various methods of prevention, control and
spread of tuberculosis.  The entire premises of the Tuberculosis Association of India were
packed with competitors, their teachers and parents.  The Association gave each participant a
commendation certificate.
It intends to conduct such programmes in the near future in collaboration with the Delhi
branch and educational institutions.
